Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817199-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
11,280
Total Value
$76,266.71
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 3,760 | $1.86 | $6,993.60 | 54,657 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 20, 2026 | Sale | 3,760 | $18.42 | $69,273.11 | 50,897 | Direct | โ | View Details | |
Chief Legal Officer | Employee Stock Option (right to buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 3,760 | $0.00 | $0.00 | 8,643 | Direct | โ | View Details |